| Page 2007 | Kisaco Research
 

Ramon Richards

SVP, Securitization & Servicing Technology
Fannie Mae

Ramon Richards

SVP, Securitization & Servicing Technology
Fannie Mae

Ramon Richards

SVP, Securitization & Servicing Technology
Fannie Mae
 

Brad Nelson

VP, Business Operations
JPMorgan Chase

Brad is a VP at JPMorgan Chase and Author of “The Holistic Aspect of Continuous Improvement”.

Brad Nelson

VP, Business Operations
JPMorgan Chase

Brad Nelson

VP, Business Operations
JPMorgan Chase

Brad is a VP at JPMorgan Chase and Author of “The Holistic Aspect of Continuous Improvement”.

Throughout his career, Brad has been a Problem Solver and Change Agent helping companies solve strategic & operational challenges. A proven leader with a Fortune 500 Pedigree, he has effectively led operational teams as well as facilitated cross-functional teams to develop & execute large scale business transformation initiatives. As a Business Executive with a Technology Savvy background, Brad is a change agent for Improved Operational Efficiency, Driving Top Line Revenue, Reduced Costs & Enhanced the Customer Experience. 

 

Shanrong Zhao

Director, Computational Biology and Bioinformatics,Pfizer Worldwide Research & Development
Pfizer

Shanrong Zhao

Director, Computational Biology and Bioinformatics,Pfizer Worldwide Research & Development
Pfizer

Shanrong Zhao

Director, Computational Biology and Bioinformatics,Pfizer Worldwide Research & Development
Pfizer
 

John Baldoni

Senior Vice President, In silico Drug Discovery
GlaxoSmithKline

John Baldoni

Senior Vice President, In silico Drug Discovery
GlaxoSmithKline

John Baldoni

Senior Vice President, In silico Drug Discovery
GlaxoSmithKline
 

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland
 

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche
 

Josep Samitier

Director
Institute for Bioengineering of Catalonia

Josep Samitier

Director
Institute for Bioengineering of Catalonia

Josep Samitier

Director
Institute for Bioengineering of Catalonia
 

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA
 

Magnus Ingelman-Sundberg

Karolinska Institutet

Magnus Ingelman-Sundberg

Karolinska Institutet

Magnus Ingelman-Sundberg

Karolinska Institutet
 

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology